Bosnic-Anticevich Sinthia, Chrystyn Henry, Costello Richard W, Dolovich Myrna B, Fletcher Monica J, Lavorini Federico, Rodríguez-Roisin Roberto, Ryan Dermot, Wan Yau Ming Simon, Price David B
Woolcock Institute of Medical Research, School of Medical Sciences, University of Sydney and Sydney Local Health District, Sydney, NSW, Australia.
Observational and Pragmatic Research Institute Pte Ltd, Singapore.
Int J Chron Obstruct Pulmon Dis. 2016 Dec 21;12:59-71. doi: 10.2147/COPD.S117196. eCollection 2017.
Patients with COPD may be prescribed multiple inhalers as part of their treatment regimen, which require different inhalation techniques. Previous literature has shown that the effectiveness of inhaled treatment can be adversely affected by incorrect inhaler technique. Prescribing a range of device types could worsen this problem, leading to poorer outcomes in COPD patients, but the impact is not yet known.
To compare clinical outcomes of COPD patients who use devices requiring similar inhalation technique with those who use devices with mixed techniques.
A matched cohort design was used, with 2 years of data from the Optimum Patient Care Research Database. Matching variables were established from a baseline year of follow-up data, and two cohorts were formed: a "similar-devices cohort" and a "mixed-devices cohort". COPD-related events were recorded during an outcome year of follow-up. The primary outcome measure was an incidence rate ratio (IRR) comparing the rate of exacerbations between study cohorts. A secondary outcome compared average daily use of short-acting beta agonist (SABA).
The final study sample contained 8,225 patients in each cohort (mean age 67 [SD, 10], 57% males, 37% current smokers). Patients in the similar-devices cohort had a lower rate of exacerbations compared with those in the mixed-devices cohort (adjusted IRR 0.82, 95% confidence interval [CI] 0.80-0.84) and were less likely to be in a higher-dose SABA group (adjusted proportional odds ratio 0.54, 95% CI 0.51-0.57).
COPD patients who were prescribed one or more additional inhaler devices requiring similar inhalation techniques to their previous device(s) showed better outcomes than those who were prescribed devices requiring different techniques.
慢性阻塞性肺疾病(COPD)患者在治疗方案中可能会被开具多种吸入器,而这些吸入器需要不同的吸入技术。既往文献表明,不正确的吸入器技术可能会对吸入治疗的效果产生不利影响。开具一系列不同类型的装置可能会使这个问题恶化,导致COPD患者的治疗效果更差,但这种影响尚不清楚。
比较使用需要相似吸入技术的装置的COPD患者与使用混合技术装置的患者的临床结局。
采用匹配队列设计,数据来自最佳患者护理研究数据库的2年数据。从随访数据的基线年份确定匹配变量,并形成两个队列:“相似装置队列”和“混合装置队列”。在随访的结局年份记录与COPD相关的事件。主要结局指标是发病率比(IRR),用于比较研究队列之间的急性加重率。次要结局比较短效β受体激动剂(SABA)的平均每日使用量。
每个队列的最终研究样本包含8225名患者(平均年龄67岁[标准差,10],57%为男性,37%为当前吸烟者)。与混合装置队列中的患者相比,相似装置队列中的患者急性加重率更低(调整后的IRR为0.82,95%置信区间[CI]为0.80 - 0.84),且不太可能属于高剂量SABA组(调整后的比例优势比为0.54,95%CI为0.51 - 0.57)。
与被开具需要不同技术的装置的患者相比,被开具一种或多种需要与之前装置相似吸入技术的额外吸入器装置的COPD患者表现出更好的结局。